257 related articles for article (PubMed ID: 34663454)
1. Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease.
Rimal S; Li Y; Vartak R; Geng J; Tantray I; Li S; Huh S; Vogel H; Glabe C; Grinberg LT; Spina S; Seeley WW; Guo S; Lu B
Acta Neuropathol Commun; 2021 Oct; 9(1):169. PubMed ID: 34663454
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
Devi L; Ohno M
Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M
Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262
[TBL] [Abstract][Full Text] [Related]
4. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
[TBL] [Abstract][Full Text] [Related]
5. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease.
Wang BJ; Her GM; Hu MK; Chen YW; Tung YT; Wu PY; Hsu WM; Lee H; Jin LW; Hwang SL; Chen RP; Huang CJ; Liao YF
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3129-E3138. PubMed ID: 28351972
[TBL] [Abstract][Full Text] [Related]
6. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
7. Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer's Disease?
Lauritzen I; Pardossi-Piquard R; Bourgeois A; Bécot A; Checler F
Curr Alzheimer Res; 2019; 16(5):453-457. PubMed ID: 30907322
[TBL] [Abstract][Full Text] [Related]
8. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease.
García-González L; Paumier JM; Louis L; Pilat D; Bernard A; Stephan D; Jullien N; Checler F; Nivet E; Khrestchatisky M; Baranger K; Rivera S
FASEB J; 2021 Jul; 35(7):e21727. PubMed ID: 34117802
[TBL] [Abstract][Full Text] [Related]
9. RACK1 and IRE1 participate in the translational quality control of amyloid precursor protein in Drosophila models of Alzheimer's disease.
Li Y; Liu D; Zhang X; Rimal S; Lu B; Li S
J Biol Chem; 2024 Mar; 300(3):105719. PubMed ID: 38311171
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
11. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
[TBL] [Abstract][Full Text] [Related]
12. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
13. RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation.
Xie Z; Dong Y; Maeda U; Xia W; Tanzi RE
J Biol Chem; 2007 Feb; 282(7):4318-4325. PubMed ID: 17170108
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
[TBL] [Abstract][Full Text] [Related]
16. Specific antibody binding to the APP672-699 region shifts APP processing from α- to β-cleavage.
Li S; Deng J; Hou H; Tian J; Giunta B; Wang Y; Sawmiller D; Smith A; Sanberg PR; Obregon D; Mori T; Tan J
Cell Death Dis; 2014 Aug; 5(8):e1374. PubMed ID: 25118934
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of Alzheimer's β-amyloid precursor protein.
Zhang H; Ma Q; Zhang YW; Xu H
J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):9-21. PubMed ID: 22122372
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
Volloch V; Olsen B; Rits S
Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
[TBL] [Abstract][Full Text] [Related]
20. Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis.
Virata MJ; Zeller RW
Dis Model Mech; 2010; 3(5-6):377-85. PubMed ID: 20197417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
